The 3rd Spatial Biology for Drug Development Summit – *Free to Attend for Biopharma Experts

On Aug 7, 2025

The 3rd Spatial Biology for Drug Development Summit
Boston, MA | October 22-23, 2025
*Free to Attend for Biopharma Experts

Spatial biology is at a turning point. Advances in resolution, sensitivity, and multi-omics integration are driving more meaningful clinical insights. High-profile collaborations such as GSK with Relation Therapeutics and Sanofi with Owkin reflect the growing momentum and confidence across the sector. Yet challenges remain around data standardization, integration, scalability, and cost, especially for small and mid-sized biopharma.

The 3rd Spatial Biology for Drug Development is a highly valuable summit that brings together leading biopharma and technology providers to address these challenges head-on through practical examples, proven strategies, and clear value stories that demonstrate how spatial biology can deliver return on investment across discovery, translational research, and clinical development.

Don’t take our word for it, hear from one of our experts:

“Attending the 3rd Spatial Biology for Drug Development Summit offers a valuable opportunity to stay current with emerging technologies, gain insights into translational applications, network with industry leaders, and explore potential collaborations that can accelerate drug development efforts.”

Associate Director – Spatial Transcriptomics, Takeda

🌟 Spotlight Speakers: Meet the 2025 Industry Leaders (including 90% Brand New Speakers)

Michael Surace, Director, Translational Medicine, Cancer Biomarker Discovery, AstraZeneca
Alexander Klimowicz, Principal Scientist, Boehringer Ingelheim
Guneet Walia, Senior Director, Data Science & Digital Health, Johnson & Johnson
Vipul Baxi, Executive Director – Computational Imaging & Digital Biomarkers, Amgen
Timothy Holzer, Executive Director – Clinical Diagnostics Laboratory, Eli Lilly

📄 View the current lineup here.

A Glimpse at Our Key Agenda Topics:

This year’s program is built around the most urgent challenges based on feedback directly from the industry:

Overcoming the Lack of Standardization & Reproducibility
Unleashing the Translational Impact of Spatial Biology
Identifying Novel Biomarkers
Building Internal Spatial Bio Data Infrastructure
Bridging Histopathology & Spatial Omics

Is It Really *Free to Attend for Biopharma?

Yes! This really is a *free-to-attend Summit for drug developers, academics & researchers** who are not actively selling services or platforms to others at industry events. You can review the full terms and conditions here or contact us directly at info@hansonwade.com to confirm your eligibility for a *complimentary pass – 90% of our audience qualifies!

Why Is It *Free to Attend for Biopharma?

We are committed to ensuring that this critical area, growing at unprecedented rates and with the potential to truly revolutionize oncology, has a platform to unite, collaborate, and drive progress. By removing barriers for attendance, we aim to bring together the brightest minds in biopharma to maximize the value of spatial biology for deeper disease insights, robust target identification, biomarker discovery, and more.

Secure your free ticket here: https://spatialbiology-drugdevelopment.com/take-part/register/

For Partnership Opportunities: Ezgi Vedat-Irikzade – Partnerships Director
sponsor@hansonwade.com

For Attendance Opportunities: Rushil Boorgula – Delegate Audience Manager
info@hansonwade.com